

OUR TURN-KEY™ MODEL
Specializing in Target-to-IND stage projects that require one of the following:
-
Create fresh NCE IP
-
100% small molecule expertise
-
Create and expand discovery pipelines and IP portfolios
-
Custom / challenging chemistry, proteomics and in vitro assays
-
Turn-key support on program build-outs, fundraising, monetization and drug development
